Acquired Coagulation Factor Deficiency

Prothrombin Complex Concentrate for Anticoagulant Reversal
NCT00168077 | PHASE 3 | INTERVENTIONAL

Patients on oral anticoagulants need rapid reversal of the anticoagulant effect in case of acute bleeding or emergency surgery. Prothrombin Complex Concentrates are known to provide a fast reversal of the anticoagulant effect, with several advantages over alternatives like vitamin K or FFP.The planned clinical Phase III study is designed to provide clinically relevant data on efficacy and safety.

Trial Information
15 Sites
40 Participants
Recruiting
18 Years to 11 Years

If interested, contact clinicaltrials@cslbehring.com for more information

CSL Behring respects your privacy. For an explanation of how CSL Behring will use the information you are submitting, please view our Privacy Policy

SUBMIT
Clinical Trials Registration Coordinator
Feldkirch,Austria,6800
Clinical Trials Registration Coordinator
Wien,Austria,1090
Clinical Trials Registration Coordinator
Halle/Saale,Germany,06112
Clinical Trials Registration Coordinator
Hannover,Germany,30623
Clinical Trials Registration Coordinator
Leipzig,Germany,04129
For information on sites in Europe, please contact our clinical research team in
Marburg,Germany,35002
Clinical Trials Registration Coordinator
München,Germany,81377
Clinical Trials Registration Coordinator
Györ,Hungary,9023
Clinical Trials Registration Coordinator
Veszprém,Hungary,8220
Clinical Trials Registration Coordinator
Haifa,Israel,31096
Clinical Trials Registration Coordinator
Kaunas,Lithuania,500009
Clinical Trials Registration Coordinator
Vilnius,Lithuania,08661
Clinical Trials Registration Coordinator
Amsterdam,Netherlands,1105AZ
Clinical Trials Registration Coordinator
Warsaw,Poland,02-097
Clinical Trials Registration Coordinator
Zuerich,Switzerland,8091

Study Eligibility Criteria

Additional Studies

Additional studies can be found at ClinicalTrials.gov